Parameter | Variables included in the cost | Average (2018) USD |
---|---|---|
Screening | Consultation fee | 41 |
Prostate Specific Antigen (PSA) | 16 | |
Digital rectal examination (DRE) | 32 | |
Diagnosis | ||
Pathology | TRUS guided Biopsy | 147 |
Radiology | Computed Tomography (CT scan)- to rule out chest, abdomen and pelvis metastasis | 862 |
Magnetic resonance imaging scan (MRI) | 1,034 | |
X-ray to rule out effusion | 28 | |
Bone scan in locally advanced prostate cancer | 607 | |
Ultrasound scan | 103 | |
Treatment | ||
Watchful Waiting (WW) cost include PSA test every three months and follow up consultation fee | PSA plus follow-up consultation fee | 58 |
Surgery | Radical prostatectomy | 5,726 |
Orchiectomy | 5,726 | |
Radiotherapy | Administered at 5 function of a 5-week period | 16,647 |
Chemotherapy (Brachytherapy or external beam radiation | Administered in 5 cycles over 5-week period | 7,498 |
Androgen Deprivation Therapy (ADT) | Mostly Zoladex o.8 mg intramuscular (IM) for every 3 months | 1,268 |
Symptoms relieving procedures (TURP/TURB) | Transurethral resection of the prostate or bladder (TURP/TURB) | 5,872 |
Other direct costs | ||
Hospitalization costs (local) | Admitted for symptoms management procedures including transurethral resection of the prostate (TURP) and orchidectomy | 5,872 |
Hospital admission in step down facility for late stage treatment (In South Africa) | Patient who require close monitoring following radiotherapy or surgery in hospital outside Eswatini | 1,206 |
Transport and lodging cost in South Africa | All patients who received treatment in South Africa | 5,959 |
Follow-up care (Year 1 following completing treatment) Follow-up is done using PSA testing, symptomology and clinical examination for metastatic cancer twice in a year | Follow up consultation, PSA tests. | 94 |
Total | 58,796 |